{"id":"W2784719900","doi":"10.1002/hep.29541","title":"Glecaprevir/pibrentasvir for hepatitis C virus genotype 3 patients with cirrhosis and/or prior treatment experience: A partially randomized phase 3 clinical trial","year":2017,"lang":"en","type":"article","venue":"Hepatology","topic":"Hepatitis C virus research","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Ribavirin; Internal medicine; Sofosbuvir; Cirrhosis; Gastroenterology; Adverse effect; Discontinuation; Pegylated interferon; Randomized controlled trial; Hepatitis C; Hepatitis C virus; Clinical endpoint; Population; Surgery; Immunology; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003198478,0.001427395,0.001856162,0.0003639323,0.0004889675,0.0008581002,0.0006915389,0.001387856,0.004681342],"category_scores_gemma":[0.001723368,0.0005539181,0.001734592,0.0004047447,0.001055854,0.0007205739,0.0004037763,0.002055503,0.0007786995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006272326,"about_ca_system_score_gemma":0.001984934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009137113,"about_ca_topic_score_gemma":0.002245015,"domain_scores_codex":[0.9989502,0.0006770173,0.00004567764,0.0001011682,0.00008020369,0.0001456629],"domain_scores_gemma":[0.9990471,0.0002164533,0.0002097183,0.00008867414,0.00005745278,0.0003805665],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9552113,0.01623063,0.001807691,0.0004159941,0.0007692454,0.00009206145,0.00008421898,0.0004853785,0.004402704,0.0001405309,0.001019799,0.01934063],"study_design_scores_gemma":[0.9243924,0.07245211,0.001790095,0.00001534274,0.0001513599,0.00004278361,0.00001177964,0.0003620725,0.0002782797,0.00008097832,0.000412494,0.00001020951],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863065,0.001921637,0.0006286369,0.0005688785,0.000179966,0.00763223,0.0009235029,0.0001257309,0.001712897],"genre_scores_gemma":[0.9840105,0.001567586,0.002019133,0.001556689,0.0002794504,0.007254593,0.001518899,0.00002689544,0.001766331],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004681342,"threshold_uncertainty_score":0.01691538,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1280204162060008,"score_gpt":0.465570049319711,"score_spread":0.3375496331137102,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}